Blackstone buys portfolio from Brookfield for $20bn life-science real estate fund
Blackstone to add $3.45bn of assets to long-term vehicle that owns BioMed Realty platform
You have now reached your article limit
Already a registered user or subscriber? Sign in here
To continue reading, register free today for access
Registration also includes access to
Five reasons to register today
- Access IPE Real Assets articles
- Daily news alerts and updates
- Track what the world’s leading institutional investors are doing
- Learn about the latest industry research and market analysis
- Comprehensive archive of data and intelligence on investors and fund managers
Copyright © 1997–2024 IPE International Publishers Limited, Registered in England, Reg No. 3233596, VAT No. 685 1784 92. Registered Office: 1 Kentish Buildings, 125 Borough High Street, London SE1 1NP